Boundless starts IPO spring with $100M listing for cancer small molecules
$BOLD will take flight on Thursday morning.
Boundless Bio, a San Diego cancer biotech, will raise about $100 million in its initial public offering by …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
